DAIC

MARCH 14, 2025

The Transplant Company recently announced that AlloSureis now commercially available for pediatric heart transplant patients of all ages and patients who have received a simultaneous pancreas-kidney (SPK) transplant. 5 As with other organ transplants, the organs are at risk of rejection.

Heart Transplant 87

Heart Transplant Transplant Pediatrics Quality of Life 87

Cardiovascular Diabetology

JUNE 20, 2024

Pretransplant type 2 diabetes mellitus (T2DM) is associated with increased cardiovascular and all-cause mortality after heart transplant (HT), but the underlying causes of this association remain unclear.

Heart Transplant 52

Heart Transplant Transplant Diabetes Research 52

Journal of the American Heart Association

FEBRUARY 29, 2024

Journal of the American Heart Association, Ahead of Print. BackgroundAnnual heart transplant (HT) volumes have increased, as have post‐HT outpatient care needs. days), and comorbidity burden was high: 42% had hypertension, 38% had diabetes, and 31% had ≥2 comorbidities. Length of stay was 3.1 days (interquartile range, 1.6–5.9

Heart Transplant 40

Heart Transplant Transplant Hospital Outpatient 40

MIBHS

OCTOBER 31, 2024

Left Ventricular Assist Device (LVAD) , a mechanical pump that helps the heart pump blood more effectively. Implantable Cardioverter-Defibrillator (ICD) to help manage dangerous heart rhythms. Heart Transplant may be considered in severe cases where other treatments have failed. Avoid excessive alcohol and drug use.

Blood Pressure 52

Blood Pressure Blood Clot Heart Valves Heart Rhythm 52

Dr. Paddy Barrett

MAY 3, 2024

While it is true that the older you are, the higher the risk of a heart attack, the process of plaque buildup starts early in life. Over half of all ‘healthy’ heart arteries examined before being used for a heart transplant were shown to have evidence of early plaque buildup. 33 years of age. No symptoms.

Heart Attack 105

Heart Attack Heart attacks Blood Pressure Risk Factors 105

Circulation: Heart Failure

JANUARY 16, 2025

However, no biomarker reflecting RVD is available for routine clinical use.METHODS:Proteomic analysis of myocardium from the left ventricle and right ventricle (RV) of patients with heart failure with reduced ejection fraction with (n=10) and without RVD (n=10) who underwent heart transplantation was performed. for both).

Biomarkers 40

Biomarkers Heart Failure Heart Transplant Transplant 40

Cardiology Update

APRIL 9, 2024

STEP-HFpEF DM 5 ( NCT04916470 ) explored the effects of semaglutide in obesity-related HF with preserved ejection fraction (HFpEF) and type 2 diabetes. The primary endpoint was a composite of all-cause mortality, left ventricular assist device (LVAD)/heart transplantation, HF hospitalizations, worsening HF, and KCCQ score changes.

Angina 52

Angina Myocardial Infarction Aortic valve Coronary Artery Disease 52